Home › Companies › VAXCYTE INC. › 2023-2024
Compiled from SEC Form N-PX filings and VAXCYTE INC.’s Form 8-K, filed June 10, 2024 (Item 5.07 on EDGAR). Page generated October 25, 2026.
Meeting of June 6, 2024: 5 items on VAXCYTE INC.’s Form 8-K, filed June 10, 2024: 2 approved · 3 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore VAXCYTE INC. in the interactive database Compare manager voting policies
These tallies are VAXCYTE INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 10, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Annie Drapeau | 82,886,170 | -- | -- | 16,143,582 | 4,817,013 | 84% | Not verified | — |
| Elect Director: Teri Loxam | 96,840,846 | -- | -- | 2,188,906 | 4,817,013 | 98% | Not verified | — |
| Elect Director: Carlos Paya, M.D., Ph.D. | 96,685,408 | -- | -- | 2,344,344 | 4,817,013 | 98% | Not verified | — |
| 2. The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. The appointment | 103,807,993 | 14,745 | 24,027 | -- | -- | 99.9% | Approved | — |
| 3. The approval, on a non-binding, advisory basis of the compensation of the Company's named executive officers. The approval of the non-binding resolution on named executive officer compensation | 91,072,269 | 7,934,248 | 23,235 | -- | 4,817,013 | 92% | Approved | — |
Source: VAXCYTE INC., Form 8-K, filed with the SEC on June 10, 2024 — read the filing on EDGAR.
Each item below shows how the 305 asset managers that disclosed a VAXCYTE INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 8 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors Nominees would serve until the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Annie Drapeau
VAXCYTE INC.’s own tally for this item (“Elect Director: Annie Drapeau”): 82,886,170 for, 16,143,582 withheld, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 108 asset managers below reported 50,146,931 for, 72 against, 7,174,902 withheld, 1,400,247 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,891,803 | 0 | 0 | 20,579 | For |
| Vanguard | 12,083,278 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 3,891,173 | 0 | 0 | 933,284 | Mixed |
| T. Rowe Price | 4,492,337 | 0 | 0 | 0 | For |
| BlackRock | 4,344,959 | 0 | 0 | 0 | For |
| Capital Group | 3,719,065 | 0 | 0 | 0 | For |
| State Street | 1,066,769 | 0 | 0 | 39,120 | For |
| FRANKLIN STRATEGIC SERIES | 911,602 | 0 | 0 | 0 | For |
| JPMorgan | 876,111 | 0 | 0 | 0 | For |
| Charles Schwab | 835,423 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 657,206 | 0 | 0 | 0 | For |
| Prudential/PGIM | 644,862 | 0 | 0 | 3,697 | For |
| AllianceBernstein | 0 | 0 | 0 | 633,068 | Withhold |
| Invesco | 0 | 0 | 0 | 614,853 | Withhold |
| Equitable | 291,588 | 0 | 0 | 234,119 | Mixed |
| Bridge Builder Trust | 19,764 | 0 | 483,120 | 0 | Abstain |
| Federated Hermes | 425,750 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 0 | 0 | 411,801 | 0 | Abstain |
| American Century | 0 | 0 | 0 | 404,240 | Withhold |
| Jackson National | 117,592 | 0 | 286,361 | 0 | Mixed |
| NEW ECONOMY FUND | 396,483 | 0 | 0 | 0 | For |
| Hartford | 386,424 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 0 | 0 | 0 | 360,895 | Withhold |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 314,955 | Withhold |
| Lord Abbett | 0 | 0 | 0 | 305,355 | Withhold |
Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.
Combines 8 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors Nominees would serve until the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Carlos Paya, M.D., Ph.D.
VAXCYTE INC.’s own tally for this item (“Elect Director: Carlos Paya, M.D., Ph.D.”): 96,685,408 for, 2,344,344 withheld, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 108 asset managers below reported 57,332,912 for, 1,370,628 withheld, 18,612 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,891,803 | 0 | 0 | 20,579 | For |
| Vanguard | 12,083,278 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,824,457 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,492,337 | 0 | 0 | 0 | For |
| BlackRock | 4,344,959 | 0 | 0 | 0 | For |
| Capital Group | 3,719,065 | 0 | 0 | 0 | For |
| State Street | 1,104,715 | 0 | 0 | 1,174 | For |
| FRANKLIN STRATEGIC SERIES | 911,602 | 0 | 0 | 0 | For |
| JPMorgan | 876,111 | 0 | 0 | 0 | For |
| Charles Schwab | 835,423 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 657,206 | 0 | 0 | 0 | For |
| Prudential/PGIM | 648,559 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 0 | 0 | 633,068 | Withhold |
| Invesco | 614,853 | 0 | 0 | 0 | For |
| Equitable | 291,588 | 0 | 0 | 234,119 | Mixed |
| Bridge Builder Trust | 502,884 | 0 | 0 | 0 | For |
| Federated Hermes | 425,750 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 411,801 | 0 | 0 | 0 | For |
| American Century | 404,240 | 0 | 0 | 0 | For |
| Jackson National | 403,953 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 396,483 | 0 | 0 | 0 | For |
| Hartford | 386,424 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 360,895 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 314,955 | Withhold |
| Lord Abbett | 305,355 | 0 | 0 | 0 | For |
Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.
Combines 8 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors Nominees would serve until the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Teri Loxam
VAXCYTE INC.’s own tally for this item (“Elect Director: Teri Loxam”): 96,840,846 for, 2,188,906 withheld, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 108 asset managers below reported 57,343,457 for, 1,360,083 withheld, 18,612 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,891,803 | 0 | 0 | 20,579 | For |
| Vanguard | 12,083,278 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,824,457 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,492,337 | 0 | 0 | 0 | For |
| BlackRock | 4,344,959 | 0 | 0 | 0 | For |
| Capital Group | 3,719,065 | 0 | 0 | 0 | For |
| State Street | 1,104,715 | 0 | 0 | 1,174 | For |
| FRANKLIN STRATEGIC SERIES | 911,602 | 0 | 0 | 0 | For |
| JPMorgan | 876,111 | 0 | 0 | 0 | For |
| Charles Schwab | 835,423 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 657,206 | 0 | 0 | 0 | For |
| Prudential/PGIM | 648,559 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 0 | 0 | 633,068 | Withhold |
| Invesco | 614,853 | 0 | 0 | 0 | For |
| Equitable | 291,588 | 0 | 0 | 234,119 | Mixed |
| Bridge Builder Trust | 502,884 | 0 | 0 | 0 | For |
| Federated Hermes | 425,750 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 411,801 | 0 | 0 | 0 | For |
| American Century | 404,240 | 0 | 0 | 0 | For |
| Jackson National | 403,953 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 396,483 | 0 | 0 | 0 | For |
| Hartford | 386,424 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 360,895 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 314,955 | Withhold |
| Lord Abbett | 305,355 | 0 | 0 | 0 | For |
Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.
Combines 12 wordings of this item as funds reported it.
92% Approved · of votes cast
Description as filed by funds: Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.
VAXCYTE INC.’s own tally for this item (“3. The approval, on a non-binding, advisory basis of the compensation of the Company's named executive officers. The approval of the non-binding resolution on named executive officer compensation”): 91,072,269 for, 7,934,248 against — passed, per its Form 8-K filed June 10, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The approval of the non-binding resolution on named executive officer compensation was approved by the votes indicated:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,912,382 | 0 | 0 | 0 | For |
| Vanguard | 12,083,278 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,824,457 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,492,337 | 0 | 0 | 0 | For |
| BlackRock | 4,344,959 | 0 | 0 | 0 | For |
| Capital Group | 0 | 3,719,065 | 0 | 0 | Against |
| State Street | 1,103,385 | 2,504 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 911,602 | 0 | 0 | 0 | For |
| JPMorgan | 876,111 | 0 | 0 | 0 | For |
| Charles Schwab | 835,423 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 657,206 | 0 | 0 | 0 | For |
| Prudential/PGIM | 648,559 | 0 | 0 | 0 | For |
| AllianceBernstein | 633,068 | 0 | 0 | 0 | For |
| Invesco | 0 | 614,853 | 0 | 0 | Against |
| Equitable | 525,707 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 502,884 | 0 | 0 | 0 | For |
| Federated Hermes | 425,750 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 411,801 | 0 | 0 | 0 | For |
| American Century | 0 | 404,240 | 0 | 0 | Against |
| Jackson National | 248,085 | 155,868 | 0 | 0 | Mixed |
| NEW ECONOMY FUND | 0 | 396,483 | 0 | 0 | Against |
| Hartford | 386,424 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 0 | 360,895 | 0 | 0 | Against |
| AB DISCOVERY GROWTH FUND, INC. | 314,955 | 0 | 0 | 0 | For |
| Lord Abbett | 305,355 | 0 | 0 | 0 | For |
Fund voting reports, all 107 managers: 52,132,614 for, 6,536,141 against, 20,481 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 15,266,690 | 0 | 0 | 0 | For |
| Janus Henderson | 7,490,808 | 0 | 0 | 0 | For |
| T. Rowe Price | 6,528,318 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 6,212,874 | 0 | 0 | 0 | For |
| Wellington | 4,552,913 | 0 | 0 | 0 | For |
| Capital Research Global Investors | 0 | 4,140,113 | 0 | 0 | Against |
| State Street | 3,034,259 | 2,636 | 0 | 0 | For |
| BlackRock | 2,981,047 | 10,058 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 1,883,810 | 0 | 0 | 0 | For |
| AllianceBernstein | 1,637,418 | 0 | 0 | 0 | For |
| FRED ALGER MANAGEMENT, LLC | 60,662 | 1,239,173 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 1,245,205 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,158,912 | 0 | 0 | 0 | For |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1,040,521 | 50,001 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 1,071,252 | 2,276 | 0 | 0 | For |
| JPMorgan | 1,045,818 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 1,034,692 | 0 | 0 | 0 | For |
| COMMODORE CAPITAL LP | 860,000 | 0 | 0 | 0 | For |
| Charles Schwab | 854,408 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 849,186 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 845,000 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 769,728 | 0 | 0 | 0 | For |
| Invesco | 0 | 765,595 | 0 | 0 | Against |
| PERCEPTIVE ADVISORS LLC | 715,159 | 0 | 0 | 0 | For |
| Kynam Capital Management, LP | 0 | 0 | 0 | 642,913 | Withhold |
Institutional-manager reports, all 227 managers: 71,034,606 for, 7,303,240 against, 642,913 withheld, 224 not voted, 106,024 1 year. Showing the 25 largest; see all in the interactive database.
Combines 5 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
VAXCYTE INC.’s own tally for this item (“2. The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. The appointment”): 103,807,993 for, 14,745 against — passed, per its Form 8-K filed June 10, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The appointment was ratified by the votes indicated:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 109 asset managers below reported 58,696,186 for, 6,241 against, 20,481 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,912,382 | 0 | 0 | 0 | For |
| Vanguard | 12,083,278 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,824,457 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,492,337 | 0 | 0 | 0 | For |
| BlackRock | 4,344,959 | 0 | 0 | 0 | For |
| Capital Group | 3,719,065 | 0 | 0 | 0 | For |
| State Street | 1,105,889 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 911,602 | 0 | 0 | 0 | For |
| JPMorgan | 876,111 | 0 | 0 | 0 | For |
| Charles Schwab | 835,423 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 657,206 | 0 | 0 | 0 | For |
| Prudential/PGIM | 648,559 | 0 | 0 | 0 | For |
| AllianceBernstein | 633,068 | 0 | 0 | 0 | For |
| Invesco | 614,853 | 0 | 0 | 0 | For |
| Equitable | 525,707 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 502,884 | 0 | 0 | 0 | For |
| Federated Hermes | 425,750 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 411,801 | 0 | 0 | 0 | For |
| American Century | 404,240 | 0 | 0 | 0 | For |
| Jackson National | 403,953 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 396,483 | 0 | 0 | 0 | For |
| Hartford | 386,424 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 360,895 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 314,955 | 0 | 0 | 0 | For |
| Lord Abbett | 305,355 | 0 | 0 | 0 | For |
Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 108,755,731 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 11.87% |
| 2 | Vanguard | 11.11% |
| 3 | JANUS INVESTMENT FUND | 4.44% |
| 4 | T. Rowe Price | 4.13% |
| 5 | BlackRock | 4.00% |
| 6 | Capital Group | 3.42% |
| 7 | State Street | 1.02% |
| 8 | FRANKLIN STRATEGIC SERIES | 0.84% |
| 9 | JPMorgan | 0.81% |
| 10 | Charles Schwab | 0.77% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 14.04% |
| 2 | Janus Henderson | 6.89% |
| 3 | T. Rowe Price | 6.00% |
| 4 | RA CAPITAL MANAGEMENT, L.P. | 5.71% |
| 5 | Wellington | 4.19% |
| 6 | Capital Research Global Investors | 3.81% |
| 7 | State Street | 2.79% |
| 8 | BlackRock | 2.75% |
| 9 | FRANKLIN ADVISERS INC | 1.73% |
| 10 | AllianceBernstein | 1.51% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| FMR LLC | 13.07% | DEF14A |
| FMR (Fidelity) | 11.50% | 13F |
| Vanguard Group | 11.33% | 13F |
| BlackRock | 9.15% | 13F |
| RA Capital Management, L.P. | 8.91% | DEF14A |
| Janus Henderson Group plc | 6.42% | DEF14A |
| State Street | 3.07% | 13F |
| T. Rowe Price | 2.92% | 13F |
| Geode Capital | 2.10% | 13F |
| Franklin Templeton | 1.97% | 13F |
Percentages above are of 108,755,731 shares outstanding, as reported by VAXCYTE INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VAXCYTE INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.
At VAXCYTE INC.'s shareholder meeting held June 6, 2024, in the 2023-2024 proxy season, 305 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 2,476 separate fund positions. On the most widely held item on that ballot — Approval, on a non-binding, advisory basis, of the compensation of the Company's named… — VAXCYTE INC.'s filing reports the proposal as approved, with 92% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: VAXCYTE INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 10, 2024.
VAXCYTE INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.